[(6aR,7R,10aS)-1,4-difluoro-10a-[4-(trifluoromethyl)phenyl]sulfonyl-6,6a,7,8,9,10-hexahydrobenzo[c]chromen-7-yl]methanol | 1100362-49-9

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: [(6aR,7R,10aS)-1,4-difluoro-10a-[4-(trifluoromethyl)phenyl]sulfonyl-6,6a,7,8,9,10-hexahydrobenzo[c]chromen-7-yl]methanol
• CAS: 1100362-49-9
• 化学式: C₂₁H₁₉F₅O₄S
• 分子量: 462.437
• InChiKey: IODISKWOIXTJAT-LCMPSIMXSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4
• 重原子数：
  31
• 可旋转键数：
  3
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.43
• 拓扑面积：
  72
• 氢给体数：
  1
• 氢受体数：
  9

反应信息

• 作为反应物：
  描述：

  [(6aR,7R,10aS)-1,4-difluoro-10a-[4-(trifluoromethyl)phenyl]sulfonyl-6,6a,7,8,9,10-hexahydrobenzo[c]chromen-7-yl]methanol 在 戴斯-马丁氧化剂 作用下， 以 二氯甲烷 为溶剂， 以90%的产率得到(6aR,7R,10aS)-1,4-difluoro-10a-((4-(trifluoromethyl)phenyl)sulfonyl)-6a,7,8,9,10,10a-hexahydro-6H-benzo[c]chromene-7-carbaldehyde
  参考文献：
  名称：

  Tricyclic sulfones as orally active γ-secretase inhibitors: Synthesis and structure–activity relationship studies

  摘要：

  Tricyclic sulfones were designed as gamma-secretase inhibitors and found to have excellent potency. Extensive SAR shows that a large number of sulfonamides at position 7 of the tricycle are very well tolerated. Compounds such as 15a and 15c showed remarkable in vivo potency. (C) 2010 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2010.04.104
• 作为产物：
  描述：

  在 锂硼氢 作用下， 以 四氢呋喃 为溶剂， 生成 [(6aR,7R,10aS)-1,4-difluoro-10a-[4-(trifluoromethyl)phenyl]sulfonyl-6,6a,7,8,9,10-hexahydrobenzo[c]chromen-7-yl]methanol 、
  参考文献：
  名称：

  Tricyclic sulfones as orally active γ-secretase inhibitors: Synthesis and structure–activity relationship studies

  摘要：

  Tricyclic sulfones were designed as gamma-secretase inhibitors and found to have excellent potency. Extensive SAR shows that a large number of sulfonamides at position 7 of the tricycle are very well tolerated. Compounds such as 15a and 15c showed remarkable in vivo potency. (C) 2010 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2010.04.104

文献信息

• Benzenesulfonyl-chromane, thiochromane, tetrahydronaphthalene and related gamma secretase inhibitors
  申请人：Asberom Theodros

  公开号：US20070197581A1

  公开（公告）日：2007-08-23

  This invention discloses novel gamma secretase inhibitors of the formula: R 2 and R 3 , or R 2 and R 4 , or R 3 and R 4 , together with the atoms to which they are bound, can form a fused cycloalkyl or fused heterocycloalkyl ring. The cycloalkyl ring or the heterocycloalkyl ring can be optionally substituted with one or more substitutents. One or more compounds of formula (I), or formulations comprising such compounds, may be useful, e.g. in treating Alzheimer's Disease.

  该发明揭示了新型伽马分泌酶抑制剂的公式：R2和R3，或R2和R4，或R3和R4，连同它们所结合的原子，可以形成融合的环烷基或融合的杂环烷基环。环烷基环或杂环烷基环可以选择性地被一个或多个取代基取代。公式（I）的一个或多个化合物，或包含这些化合物的制剂，可以用于治疗阿尔茨海默病等疾病。
• BENZENESULFONYL-CHROMANE, THIOCHROMANE, TETRAHYDRONAPHTHALENE AND RELATED GAMMA SECRETASE INHIBITORS
  申请人：Asberom Theodros

  公开号：US20120264736A1

  公开（公告）日：2012-10-18

  This invention discloses novel gamma secretase inhibitors of the formula: R 2 and R 3 , or R 2 and R 4 , or R 3 and R 4 , together with the atoms to which they are bound, can form a fused cycloalkyl or fused heterocycloalkyl ring. The cycloalkyl ring or the heterocycloalkyl ring can be optionally substituted with one or more substituents. One or more compounds of formula (I), or formulations comprising such compounds, may be useful, e.g. in treating Alzheimer's Disease.

  本发明公开了新的伽马分泌酶抑制剂的公式：R2和R3，或R2和R4，或R3和R4，以及它们结合的原子可以形成融合的环烷基或融合的杂环烷基环。环烷基环或杂环烷基环可以选择性地被一个或多个取代基取代。公式（I）中的一个或多个化合物，或包含这样的化合物的制剂，可能有用，例如在治疗阿尔茨海默病方面。
• TETRAHYDROPYRANOCHROMENE GAMMA SECRETASE INHIBITORS
  申请人：Wu Wen-Lian

  公开号：US20110236400A1

  公开（公告）日：2011-09-29

  Disclosed are novel gamma secretase inhibitors of the formula. Also disclosed are methods of inhibiting gamma-secretase, methods of treating neurodegenerative diseases, and methods of treating Alzheimer's Disease. Also disclosed are processes for preparing alkenes in one reaction step using a mixture of an aldehyde (or ketone) and an alkyl substituted with two electron withdrawing groups, and reacting the mixture with: (a) a sulfonyl halide (e.g., a sulfonyl chloride) and a basic tertiary amine, or, (b) a sulfonyl anhydride and a basic amine, or (c) an aryl-C(O)-halide and a basic tertiary amine, or (d) an aryl-C(O)—O—C(O)-aryl and a basic tertiary amine, or (e) an heteroaryl-C(O)-halide and a basic tertiary amine, or (f) a heteroaryl-C(O)—O—C(O)-heteroaryl and a basic tertiary amine.

  本发明涉及一种新型伽马分泌酶抑制剂的公开。还公开了抑制伽马分泌酶的方法、治疗神经退行性疾病的方法和治疗阿尔茨海默病的方法。还公开了一种使用醛（或酮）和烷基取代的两个电子提取基团的混合物，在一步反应中制备烯烃的方法，并将该混合物与：（a）磺酰卤化物（例如磺酰氯）和碱性三级胺反应，或（b）磺酰酐和碱性胺反应，或（c）芳基-C（O）-卤和碱性三级胺反应，或（d）芳基-C（O）-O-C（O）-芳基和碱性三级胺反应，或（e）杂环芳基-C（O）-卤和碱性三级胺反应，或（f）杂环芳基-C（O）-O-C（O）-杂环芳基和碱性三级胺反应。
• [EN] TETRAHYDROPYRANOCHROMENE GAMMA SECRETASE INHIBITORS<br/>[FR] INHIBITEURS DE LA TÉTRAHYDROPYRANOCHROMÈNE GAMMA SECRÉTASE
  申请人：SCHERING CORP

  公开号：WO2009008980A3

  公开（公告）日：2009-03-19
• CARBOCYCLIC AND HETEROCYCLIC ARYLSULFONES AS GAMMA SECRETASE INHIBITORS
  申请人：Merck Sharp & Dohme Corp.

  公开号：EP1976843B1

  公开（公告）日：2013-09-04